Know Cancer

or
forgot password

A Longitudinal Study of Biomarkers in Pediatric Patients With Central Nervous System Tumors


N/A
N/A
21 Years
Open (Enrolling)
Both
Central Nervous System Tumor

Thank you

Trial Information

A Longitudinal Study of Biomarkers in Pediatric Patients With Central Nervous System Tumors


Inclusion Criteria:



- Patients ages 1 day to 21 years

- Patients with radiographically and/or histologically confirmed CNS tumors treated at
Children's Memorial Hospital and Lurie Children's Hospital in Chicago

- Patients must be newly diagnosed and have had no prior anticancer therapy (except
surgery) for their current diagnosis. The use of steroids is permissible.

- Patients and/or parents/legal guardians must have signed an informed consent and
assent when applicable.

Exclusion Criteria:

- Patients who have completed treatment and do not require routine blood draws and/or
lumbar punctures

- Patients who are considered too ill to participate as determined by their treating
physician

- Patients who are pregnant or lactating

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

Presence of microRNAs and proteins in the blood, cerebrospinal fluid and urine of patients with central nervous system tumors from diagnosis through the course of their treatment

Outcome Time Frame:

24 months

Safety Issue:

No

Principal Investigator

Rishi Lulla, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Ann & Robert H Lurie Children's Hospital of Chicago

Authority:

United States: Institutional Review Board

Study ID:

2012-14877

NCT ID:

NCT01595126

Start Date:

December 2011

Completion Date:

Related Keywords:

  • Central Nervous System Tumor
  • Nervous System Neoplasms
  • Central Nervous System Neoplasms

Name

Location
Children's Memorial Hospital Chicago, Illinois  60614